Resource Library
Discover Kymera’s research and resources on our exciting platform, pipeline, and additional cutting-edge technologies.
Highlights
September 25, 2024
Poster Presentation at the European Academy of Dermatology and Venereology (EADV) 2024 Congress
Poster for KT-621, our first-in-class STAT6 degrader in immunology
Highlights
June 1, 2024
Poster Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Poster for KT-253, our MDM2 degrader in oncology
Highlights
May 22, 2024
Poster Presentation at the American Thoracic Society (ATS) 2024 Annual Meeting
Poster for KT-621, our first-in-class STAT6 degrader in immunology
Immunology
We are addressing the root molecular causes of chronic inflammatory disease.
Oncology
We are focused on unlocking novel mechanisms to help patients in need of better therapies.
Platform
Discover more about our cutting-edge toolbox of integrated approaches to accelerate the discovery and development of transformative medicines.
Targeted Protein Degradation
Our leadership in TPD is propelling novel medicines forward.